Asia stocks: China surges on stimulus hopes, others lag on fresh tariff fears
Quantum-Si Inc (NASDAQ:QSI) Chief Financial Officer Jeffry R. Keyes sold 8,624 shares of Class A Common Stock on June 23, 2025, according to a new SEC filing. The company, currently valued at $346 million, has seen its stock surge 45% over the past six months, according to InvestingPro data. The shares were sold at a weighted average price of $1.6139, for a total transaction value of $13,918.
The prices received for the shares ranged from $1.55 to $1.68. Following the transaction, Keyes directly owns 1,179,570 shares of Quantum-Si. The stock, which InvestingPro analysis indicates is currently slightly undervalued, maintains a strong liquidity position with a current ratio of 19.2.
The sale was to cover required federal, state and local withholding taxes in connection with the vesting of previously granted restricted stock units. While the company holds more cash than debt on its balance sheet, InvestingPro analysis reveals 8 additional key insights about Quantum-Si’s financial health and market position.
In other recent news, Quantum-Si Incorporated reported its Q1 2025 earnings, revealing a narrower-than-expected loss per share and a significant 84% increase in revenue compared to the previous year. The company’s earnings per share (EPS) stood at -$0.11, surpassing the forecast of -$0.17, although revenue of $842,000 fell short of the $1.25 million projection. Despite the EPS beat, the revenue miss and market challenges may have contributed to a negative reaction from investors. Quantum-Si has also announced its participation in the upcoming Festival of Genomics & Biodata Boston, where it will showcase advancements in its protein sequencing technology. Melissa Deck from Liberate Bio is set to present on the use of Quantum-Si’s Platinum Pro instrument in drug development. The company continues to invest in research and development, with plans to launch its Proteus platform in the latter half of 2026. Additionally, Quantum-Si maintains a strong cash position, with $232.6 million in cash and equivalents, providing a financial runway into the second half of 2027. The company is also expanding its international presence, having increased its network to 23 distribution partners worldwide.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.